Huashen group's second application for production of 6.1 rhinitis traditional Chinese medicine Wulong granules was accepted

According to the website of the State Food and Drug Administration (CFDA) on May 9, Wulong granules, a 6.1 rhinitis traditional Chinese medicine, which was applied for production (reexamination) by Huashen group twice, was accepted This product is one of the important R & D varieties of Huashen group However, due to the previous clinical trial design and implementation difficult to support the safety and effectiveness evaluation of this product, this product failed to obtain production approval and was rejected in February this year It is learned from Huashen group that Wulong granules are independently developed by the company and are modern compound Chinese medicine for the treatment of allergic rhinitis According to the opinion of drug audit experts, the company will put forward the application for supplementing the long-term toxicity test of animals and extending the course of clinical research to fully evaluate the effectiveness and safety of Wulong granules in the field of treatment At present, Huashen group's scientific research projects "research and development of industrialization technology of modern traditional Chinese medicine compound new medicine Wulong granules" and "clinical research of modern compound traditional Chinese medicine Wulong granules" have successively applied for the special project of technological innovation of Sichuan Economic and Information Commission and the project of incubation fund for scientific and technological achievements of Shuangliu County, and obtained special fund support Huashen group is mainly engaged in pharmaceutical manufacturing Last year, the company completely withdrew from the field of veterinary medicine and veterinary biological vaccine with low added value and uncompetitive products, and focused on the development of Chinese and Western medicine and biological medicine Huashen group said in its 2013 annual report that the smooth progress of the research and development of Wulong granules will have a positive impact on the company's strategic structure adjustment of products and sustained growth of business performance.